MYC and osteosarcoma: Unexpectedly, RNA-seq analysis revealed that pharmacological inhibition of c-Myc in osteosarcoma mainly resulted in activation of multiple immune pathways, including T-cell activation, leukocyte cell–cell adhesion, and positive regulation of defense response, rather than suppression of cell proliferation pathways (Fig. 2G).